Kedudukan dalam Saham
#33866
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Harga Saham
$0.5475
Disegerakkan terakhir: 2026-08-14
Perdagangan 20/20 Biolabs Inc. (AIDX)
Harga AIDX dengan permodalan pasaran b
Modal pasaran bagi 20/20 Biolabs Inc.(AIDX)
Modal Pasaran: $6.71M
Sehingga August 2026, 20/20 Biolabs Inc. mempunyai modal pasaran sebanyak $6.71M. Ini menjadikan 20/20 Biolabs Inc. syarikat ke-33866th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran 20/20 Biolabs Inc. dari 2026 hingga 2026
AIDX berbanding dengan 5 teratas yang paling popular stocks
| Harga AIDX |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+81,276,656.64%
|
|
|
|
|
$4.490T
|
+66,937,378.02%
|
|
|
|
|
$4.162T
|
+62,053,302.40%
|
|
|
|
|
$3.676T
|
+54,807,023.79%
|
|
|
|
|
$2.833T
|
+42,235,061.84%
|
